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Abstract
Background
Malaria in pregnancy causes maternal, fetal and neonatal morbidity and mortality, and
maternal innate immune responses are implicated in pathogenesis of these complications.
The effects of malaria exposure and obstetric and demographic factors on the early mater-
nal immune response are poorly understood.
Methods
Peripheral blood mononuclear cell responses to Plasmodium falciparum-infected erythro-
cytes and phytohemagglutinin were compared between pregnant women from Papua New
Guinea (malaria-exposed) with and without current malaria infection and from Australia
(unexposed). Elicited levels of inflammatory cytokines at 48 h and 24 h (interferon γ, IFN-γ
only) and the cellular sources of IFN-γ were analysed.
Results
Among Papua New Guinean women, microscopic malaria at enrolment did not alter periph-
eral blood mononuclear cell responses. Compared to samples from Australia, cells from
Papua New Guinean women secreted more inflammatory cytokines tumor necrosis factor-
α, interleukin 1β, interleukin 6 and IFN-γ; p<0.001 for all assays, and more natural killer cells
produced IFN-γ in response to infected erythrocytes and phytohemagglutinin. In both popu-
lations, cytokine responses were not affected by gravidity, except that in the Papua New
Guinean cohort multigravid women had higher IFN-γ secretion at 24 h (p = 0.029) and an
increased proportion of IFN-γ+ Vδ2 γδ T cells (p = 0.003). Cytokine levels elicited by a
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pregnancy malaria-specific CSA binding parasite line, CS2, were broadly similar to those
elicited by CD36-binding line P6A1.
Conclusions
Geographic location and, to some extent, gravidity influence maternal innate immunity to
malaria.
Introduction
Malaria in pregnancy is responsible for 10,000 maternal deaths annually [1] and is associated
with increased risk of miscarriage, stillbirth, fetal growth restriction, preterm deliveries, low
birth weight (LBW) and infant mortality [2–5]. These complications are particularly associated
with placental malaria, characterized by the attachment of Plasmodium falciparum-infected
erythrocytes (IE) to chondroitin sulfate A (CSA) expressed on the placental syncytiotropho-
blast. This placental adhesion is mediated by a member of the P. falciparum erythrocyte mem-
brane protein-1 (PfEMP1) family called VAR2CSA. The severity of maternal and fetal
complications varies and is influenced by factors including gravidity, malaria endemicity and
exposure [6, 7].
Partial immunity against clinical malaria develops with repeated parasite exposure. In low
and unstable malaria transmission regions, all pregnant women are at risk and P. falciparum
infections can rapidly lead to severe maternal, fetal and infant complications [7]. In contrast
adults, including pregnant women, living in high and stable transmission areas acquire a sub-
stantial level of immunity and generally experience asymptomatic infections or mild malaria
symptoms [4]. They generally have previous exposure to a wide variety of PfEMP1 variants,
which mediate adhesion to endothelial receptors such as CD36, intercellular adhesion mole-
cule 1 and endothelial protein C receptor.
In malaria-endemic areas, susceptibility to P. falciparum infections is relatively higher in
first pregnancy (primigravidae) than in later pregnancies (multigravidae) [8]. The average
prevalence of antenatal infections in Papua New Guinea (PNG) was approximately two-fold
higher in primigravidae compared to multigravidae [9, 10]. Since primigravidae have little or
no prior exposure to VAR2CSA expressing parasites, they lack sufficient VAR2CSA neutraliz-
ing antibodies and are consequently more prone to PM-associated complications [9, 10].
While the effects of malaria transmission intensity and gravidity are mainly associated with
antibody-mediated immunity, their potential impact on maternal innate immunity is not well
understood. As essential components of innate immune responses, inflammatory cytokines,
natural killer (NK) cells and γδ T cells are of particular interest in maternal and neonatal
immunity. NK cells can directly lyse target cells, activate antigen-presenting cells and promote
Th1 responses [11] while the exposure of γδ T cells to IE in vitro results in early Th1 cytokine
responses [12, 13]. However, the roles of both NK and γδ T cells in either protection from, or
the pathogenesis of, P. falciparum malaria are not clear [12, 14–16].
In normal pregnancy Th1 cytokine responses are generally suppressed, but PM can result
in placental elevation of tumor necrosis factor α (TNF-α), which is associated with both ane-
mia [17] and LBW [17, 18], while increased interferon γ (IFN-γ) levels could mediate either
protective [19] or pathogenic [17] effects. Increased levels of the chemokines interleukin 8 (IL-
8), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1 (MIP-
1) α and MIP-1 β are crucial in parasite clearance but potentially harmful to pregnancy as they
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can enhance placental infiltration of immune cells such as monocytes [20, 21], which have
been associated with anemia and LBW [22]. With these positive and negative associations, the
magnitude and response profile of inflammatory mediators could be important determinants
of pregnancy outcomes in malaria in pregnancy.
In a previous study from PNG, cytokine and chemokine secretion by peripheral blood
mononuclear cells (PBMC) stimulated with VAR2CSA-expressing CS2-IE were reported to
differ between multigravidae (2–4 pregnancies) and grand-multigravidae (5–7 pregnancies)
[23]. However, it remains unclear whether the observed immune response was affected by life-
time malaria exposure or gravidity. The present study, therefore, investigates the effect of gra-
vidity, lifetime malaria exposure, active malaria infection and different P. falciparum strains on
maternal innate immune responses.
Materials and methods
Ethics approval and consent to participate
Ethical approvals were obtained from the Royal Women’s Hospital Human Research Ethics
Committee (project 08/33), the Medical Research Advisory Council of Papua New Guinea, the
Melbourne Health Human Research Ethics Committee and Alfred Health Human Research
Ethics Committee.
All participants provided written informed consent prior to enrolment.
Study locations, participants and sample collection
Primigravid and multigravid women were recruited from health facilities in Madang Province
PNG, and the Royal Women’s Hospital, Melbourne, Australia (AUS). PNG is a malaria
endemic region, with a high intensity of rainfall and malaria transmission as previously
described [24]. Recruitment in PNG occurred between September 2005 and October 2007
[25]; Exclusion criteria included hemoglobin<5 g/dL; permanent disability and chronic medi-
cal conditions; known multiple pregnancy; unavailable for follow-up; and age<16 years.
At enrolment (14–26 gestational weeks) and prior to treatment, 10 ml peripheral blood was
collected in sodium heparin to isolate PBMC. Malaria infection was determined by peripheral
blood microscopy and a polymerase chain reaction/ligase detection reaction-fluorescent micro-
sphere assay (LDR-FMA) [25] which detected P. falciparum, P. vivax and P. ovale. Based on these
data, study samples were categorized into malaria positive and negative by light microscopy and
then grouped by gravidity. The Australian cohort comprised malaria-naïve pregnant women who
had been scheduled for elective caesarean section. Exclusion criteria were hypertension, gesta-
tional or pre-existing diabetes, and obesity (body mass index>30 kg/m2). At enrolment (>38 ges-
tation weeks), 10 ml peripheral blood was collected in ethylenediaminetetraacetic acid (EDTA)
tubes for PBMC isolation within two hours of collection. PBMC samples were categorized into six
test groups based on exposure, gravidity and current malaria infection as shown in Fig 1A.
Parasite culture and preparations
The laboratory-adapted P. falciparum lines CS2 (which binds to CSA and mimics pregnancy asso-
ciated isolates) [26] and P6A1 (a clone of the A4 parasite line that binds to CD36, gift of Professor
Joe Smith [27]) were cultivated at 5% hematocrit with human blood group O/Rhesus positive red
blood cells (RBC) from healthy volunteers provided by the Australian Red Cross blood service
(Agreement number 16-02VIC-06) as described in [28]. Cultures were screened regularly to
exclude Mycoplasma contamination using MycoAlert™ mycoplasma detection kit (Lonza) [29].
To ensure that the respective binding phenotype of the parasite lines were maintained, cultures
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were tested for adhesion to immobilized receptors and panned on immobilised CSA (CS2) or
CD36 (P6A1) as described in [30]. Cultures were synchronised by gelatine flotation for the selec-
tion of knobby trophozoite stage parasites every 1 to 2 weeks [31]. Prior to stimulation assays,
mature trophozoite IE were purified by density gradient centrifugation using layers of 80%, 60%
and 40% Percoll in supplemented RPMI 1640-HEPES as described elsewhere [32, 33].
PBMC isolation
At both sites, following whole blood dilution with warm RPMI 1640 (Gibco), PBMC were isolated
by density gradient centrifugation (700xg, 25 min) using Ficoll-Paque (GE Healthcare). Cells were
harvested and if RBC contamination was observed, samples were incubated in 0.2% NaCl (37˚C,
3 min) to lyse RBC. PBMC were then washed in cold Ca2+/Mg2+ free phosphate-buffered saline
(PBS) and aliquots frozen in 20% DMSO in fetal bovine serum (FBS) at -80˚C [34].
PBMC elicitation assay
PBMC samples were stimulated in duplicates with CS2 or P6A1 IE, uninfected RBCs (uRBC),
and mitogenic lectin phytohemagglutinin (20 μg/mL PHA, Life Technologies) as illustrated in
Fig 1B. Briefly, PBMC were thawed at 37˚C and washed twice (700xg, 10 min, room tempera-
ture) with PBMC medium (RPMI 1640, 10% FBS, 25 mM HEPES, 2 mM L-glutamine, 100 U/
Fig 1. (A) Stratification of study population: PBMC derived from pregnant women from Papua New Guinea (PNG) and Australia (AUS) were categorized into six
test groups based on sample origin, gravidity and current malaria infection. From PNG: infected primigravidae (15), infected multigravidae (15), non-infected
primigravidae (11) and non-infected multigravidae (15). From Australian: primigravidae (15) and multigravidae (15). (B) Schematic representation of PBMC
stimulation assay: PBMC were isolated by Ficoll gradient centrifugation and frozen at -80˚C. PBMC were thawed in batches and co-incubated with Percoll-purified
infected erythrocytes (IE), phytohemagglutinin (PHA) or uninfected red blood cells (uRBC) for 24 or 48 hours. At 24 hrs, supernatants were measured for IFNγ,
and cells harvested, stained and analyzed for intracellular staining. At 48 hrs, supernatant were analyzed for TNF-α, IFN-γ, IL-1β, IL-6, IL-8, IL-10, and IP-10 by
cytometric bead array. (C) Gating strategy for NK cells, γδ T cells and two distinct populations of γδ T cells (Vδ1+ and Vδ2+) producing IFN-γ. Live lymphocytes
were identified using forward scatter (FSC) and side scatter (SSC) (I) before excluding cell doublets (II). Then, NK cells (CD3-CD56+) (III), γδ T cells (CD3+ TCR+)
(IV), Vδ2 γδ T cells (γδTCR+ Vδ2+) (V) and Vδ1 γδ T cells (γδTCR+ Vδ1+) (VI) were gated on. Finally, the proportion (%) of each cell type producing IFN-γ was
determined (e.g. proportion of IFNγ producing γδ T cells in response to CS2 IE (VII) and uRBC (VIII). Quadrants defining positive and negative cell populations
were set according to single color controls. FACS plots are from one representative donor.
https://doi.org/10.1371/journal.pone.0236375.g001
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mL penicillin, 100 μg/mL streptomycin). Cell viability was assessed by trypan blue staining. In
96-well round bottom plates, 2 x 105 viable cells/well were plated and rested at 37˚C for 1 hour.
PBMC were then incubated with IE (6 x 105 per well), uRBC (6 x 105 per well) or PHA (2%),
and supernatants were analysed after 48 hours [35, 36]. PBMCs were tested in batches of 6–9
samples at a time, selected from across the different participant groups.
Cytokine measurement
A multiplex assay (Cytometric Bead Array; Flex Sets; BD Biosciences) was used to quantify
cytokine levels according to the manufacturer’s instructions. In pre-wetted 96-well round bot-
tom plates, a set of antibody-coated capture beads specific for human TNF-α, IFN-γ, IL-1β, IL-
6, IL-8, IL-10, and IP-10 were premixed and incubated with supernatants and standards. Sub-
sequent steps were carried out according to the manufacturer’s instructions. Bead suspensions
were analysed using a CyAn flow cytometer (Beckman Coulter) and fluorescence intensity was
converted to cytokine concentration using the FCAP array (version 3) or Hypercyte software.
The assay sensitivity for each cytokine was: 1.2 pg/mL (TNF-α), 1.8 pg/mL (IFN-γ), 2.3 pg/mL
(IL-1β), 1.6 pg/mL (IL-6), 1.2 pg/mL (IL-8), 0.13 pg/mL (IL-10) and 0.5 pg/mL (IP-10) [37].
Intracellular staining for IFN-γ
PBMCs were stimulated with CS2 IE or uRBC for 24 h at 37˚C in 5% CO2. (Cell numbers were
insufficient to also test P6A1). Brefeldin A (0.1 μg/mL, eBioscience) was added 6 h before har-
vesting the cells. Cells were washed (200xg, 4 minutes, 4˚C) with FACS buffer (2 mM EDTA
and 1% Heat Inactivated FBS (HI-FBS) in PBS) and stained with a panel of surface markers
[anti-CD3ε PerCP Cy5.5 (1:200; clone SP34-2, BD), CD56 APC (1:25; clone N901, Beckman
Coulter), γδ TCR (1:50; clone 11F2, BD), TCR Vδ2 BV711 (1:200; clone B6, BD or BioLegend),
TCR Vδ1 FITC (1:50; clone TS8.2, Thermo Scientific)] for 30 min on ice. All antibodies were
used at empirically determined dilutions that provided optimum signal-to-noise ratio. Cells
were washed twice with FACS buffer and stained with a fixable viability dye (aqua live/dead
amine-reactive dye; Invitrogen) for 15 min at RT for dead cell exclusion. Intracellular staining
[IFN-γ PE (1:100; clone 4S.B3, BD)] was performed using a BD Cytofix/Cytoperm ICS kit (BD
Biosciences) as per the manufacturer’s instructions. A minimum of 10000 events were
acquired on a 4-laser Fortessa flow cytometer (BD Biosciences, CA) and data were analysed
using FlowJo software version 10. Using the combination of fluorescence minus 1 (FMOs) and
single colour controls (Ultra Comp eBeads, eBioscience) as a gating strategy, the proportions
of IFN-γ+ cells (i.e. NK and γδ T cells) were determined [36].
Statistical analysis
Statistical analysis was performed using GraphPad Prism (Version 5). Data were tested for
normality using Shapiro-Wilks and Kolmogorov-Smirnov normality tests. Paired samples
were compared using Wilcoxon signed-rank test or Student’s t-test as appropriate. Unpaired
samples were compared using the Mann-Whitney U test or t-test. A probability value of<0.05
was considered significant. Results are presented as median and interquartile range (IQR), and
absolute values rounded up to integers.
Results
Clinical characteristics of the study cohort
Thirty women from Australia (AUS), 30 women from PNG with malaria infection (PNG_I)
and 26 women from PNG without malaria infection (PNG_N) were included in this study.
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The lower number in the PNG_N group was due to limited sample number. AUS and PNG_I
groups were each divided into 15 primigravid and 15 multigravid women, whiles the PNG_N
group constituted 11 primigravid and 15 multigravid women. Table 1 compares the clinical
characteristics of the study groups. The median (interquartile range) of maternal hemoglobin
[13 (11–14) vs 8 (6–10) g/dL], maternal age [33 (30–48) vs 24 (17–36) years] and gestational
age at sample collection [39 (38–40) vs 25 (19–33) weeks] were significantly higher in Austra-
lian women compared to malaria-negative PNG women. Of the infected PNG women 17 had
parasites detected by microscopy and PCR, while 13 had submicroscopic infection. Twenty
infections were with P. falciparum while ten were with P. vivax and/or P. ovale.
Effect of anticoagulant on cytokine responses
Because blood was collected in PNG in heparin, and in Melbourne it was collected in EDTA,
we compared cytokine elicitation from PBMCs collected from 4 donors which were collected
into each of the two anticoagulants. No statistically significant differences were seen in cyto-
kine elicitation between cells collected in the differing anticoagulants (S1 Fig).
Effect of current malaria infection on cellular activity and cytokine
responses
To assess the influence of current malaria infection on the responsiveness of PBMC, PNG
women were segregated according to active malaria infection at study enrolment as shown in
Table 2. Upon stimulation with CS2 IE, cytokine responses were similar between the two
groups except for IFN-γ which was moderately higher in the non-infected group at 48 h
(p = 0.026) but not at 24 h. Consistent with the 24 h observation, the proportions of IFN-γ-
secreting cells (NK and γδ T cells) were not different between the malaria-infected and non-
infected groups.
Effect of malaria exposure on cellular activity and cytokine responses
To evaluate the effect of sample origin (i.e. PNG and Australia) on innate cellular responses,
PBMC responses to CS2 and P6A1 IE were compared between Australian participants and
malaria-uninfected PNG women as noted in Table 3. Compared to those from Australia,
PBMCs from PNG produced significantly higher levels of all tested cytokines in response to
both parasite lines, including IFN-γ at both 24 h and 48 h. The proportion of IFN-γ+ NK cells
was somewhat higher (P = 0.063) in PBMC from PNG compared to samples from Australia,
Table 1. Clinical characteristics and stratification of study groups.
PNG_I PNG_ N AUS P value (PNG_I vs PNG_N) � P value (PNG_N vs AUS) �
n = 30 n = 26 n = 30
Maternal age at enrolment (years) 22 (16–32) 24 (17–36) 33 (30–48) 0.826 < 0.001
Maternal hemoglobin level (g/dL) 8.2 (5–11) 8 (6–10) 13 (11–14) 0.928 < 0.001
Recruitment gestational age (weeks) 25 (7–30) 25 (19–33) 39 (38–40) 0.563 < 0.001
PNG_I PNG_N AUS
Stratification by gravidity Primi Multi Primi Multi Primi Multi
n = 15 n = 15 n = 11 n = 15 n = 15 n = 15
Data are median (interquartile range). PNG: Papua New Guinea; I: Malaria infected women; N: Non-malaria infected women; AUS: Australia; Primi: Primigravidae;
Multi: Multigravidae
�: Mann-Whitney U Test; P values in Bold: Statistically significant.
https://doi.org/10.1371/journal.pone.0236375.t001
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but no significant differences in proportions IFN-γ+ cells were seen. Patterns of cytokine secre-
tion following stimulation with P6A1 IE were broadly similar to those using CS2 IE (Table 3),
except that there were lower levels of TNF-α (Australia), IL-8 (both PNG and Australia) and
IP-10 (PNG) produced following stimulation with P6A1 compared to CS2 (S1 Table).
Effect of gravidity on cellular activity and cytokine responses
PBMC derived from malaria-negative PNG women and Australian women were categorised
by gravidity, and their responses to CS2 IE compared in Table 4. In both study cohorts, cyto-
kine secretion at 48 h was similar between primigravid and multigravid women. However, for
the 24-hr time point, a significantly higher IFN-γ secretion was observed in multigravid com-
pared to primigravid women from PNG (347 versus 54 pg/mL; p = 0.029). A similar trend was
also observed in the Australian cohort. When intracellular cytokine staining was assessed, the
proportion of IFN-γ-producing γδ T cells (p = 0.013) and especially the Vδ2+ subset (p =
0.003) were substantially increased in multigravid women compared to primigravid women
from PNG. In contrast, the proportions of IFN-γ-producing cells were similar between primi-
gravid and multigravid women from Australia. Patterns of cytokine secretion following stimu-
lation with P6A1 IE did not differ between primigravid and multigravid women (S2 Table).
Cellular responses to non-malaria stimuli
To determine if the observations were specific to IE, cellular responses to PHA and uRBC were
compared between PNG and Australian women as shown in Table 5. In response to PHA, elic-
ited levels of TNF-α, IL-1β, IL-6, IL-8 and IL-10 (48 h: p<0.001 for all) as well as IFN-γ (24 h:
p<0.001) were significantly higher in samples from PNG compared to those from Australia.
Additionally, the proportion of IFN-γ-producing NK cells (p = 0.024) was significantly higher
Table 2. Cytokine secretion and cellular responses to CS2 IE between malaria infected and non-infected women
from PNG.
PNG_ I PNG_ N P value�
n = 30 n = 26
Cytokine levels at 48 hours (pg/ml)
TNF-α 7 (2–53) 14 (2–32) 0.993
IFN-γ 90 (6–385) 329 (134–1006) 0.026
IL-1β 8 (2–26) 7 (2–20) 0.954
IL-6 136 (29–1028) 149 (55–621) 0.902
IL-8 10535 (5808–20020) 14407 (9384–20637) 0.475
IL-10 14 (6–28) 15 (5–40) 0.844
IP-10 298 (120–903) 650 (77–2442) 0.320
IFN-γ ^^ 78 (6–567) 166 (52–545) 0.349
Percentage of IFN-γ+ cells at 24 hours
NK cells 12 (3–23) 7 (4–13) 0.320
γδ T cells 11 (4–17) 7 (5–11) 0.366
Vδ2 T cells 11 (4–21) 9 (4–18) 0.889
Vδ1 T cells 9 (2–17) 4 (2–12) 0.175
Data are median (interquartile range). PNG: Papua New Guinea; I: Malaria infected women; N: Non-malaria
infected women
�: Mann-Whitney U Test; P value in Bold: Statistically significant
^^: Cytokine level at 24 hours.
https://doi.org/10.1371/journal.pone.0236375.t002
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in PNG women compared to the Australian group. Furthermore, IFN-γ (p = 0.029), IL-6
(p = 0.005) and IL-8 (p = 0.002) responses to uRBC were significantly higher in samples from
PNG compared to those from Australia.
Table 3. Cytokine secretion and cellular responses to malaria-IE in PNG and Australian women.
CS2-IE P6A1-IE
PNG_N AUS P value � PNG_N AUS P value �
n = 26 n = 30 n = 26 n = 30
Cytokine levels at 48 hours (pg/ml)
TNF-α 14 (2–32) 4 (2–25) <0.001 10 (3–48) 2 (1–6) <0.001
IFN-γ 328 (132–1005) 16 (1–72) <0.001 334 (113–1044) 10 (1–44) <0.001
IL-1β 7 (2–20) 1 (1–1) <0.001 5 (2–39) 1 (1–1) <0.001
IL-6 149 (55–620) 7 (2–17) <0.001 90 (26–1244) 4 (1–18) <0.001
IL-8 14407 (9384–20637) 535 (102–1676) <0.001 13167 (4459–16867) 215 (65–1080) <0.001
IL-10 14 (5–40) 1 (1–1) <0.001 18 (4–38) 1 (1–1) <0.001
IP-10 650 (77–2442) 30 (1–100) <0.001 489 (32–1437) 5 (1–50) <0.001
IFN-γ ^^ 166 (52–545) 24 (7–93) <0.001 129 (51–588) 22 (7–47) <0.001
Percentage of IFN-γ+ cells at 24 hours
NK cells 11 (6–16) 8 (2–14) 0.063
γδ T cells 7 (4–10) 8 (3–11) 0.837
Vδ2 T cells 9 (4–18) 8 (3–13) 0.240
Vδ1 T cells 4 (2–12) 7 (3–15) 0.246
Data are median (interquartile range). PNG: Papua New Guinea; N: Non-Malaria Infected women; AUS: Australia
�: Mann-Whitney Test; P values in Bold: Statistically significant
^^: Cytokine level at 24 hours.
https://doi.org/10.1371/journal.pone.0236375.t003
Table 4. Cytokine secretion and cellular responses to CS2 IE between primigravid and multigravid women.
PNG_N AUS
Primi Multi P value � Primi Multi P value �
n = 11 n = 15 n = 15 n = 15
Cytokine levels at 48 hours (pg/ml)
TNF-α 20 (3–24) 8 (2–94) 0.621 1 (1–3) 1 (1–4) 0.999
IFN-γ 208 (145–607) 541 (8–1092) 0.716 10 (1–60) 19 (1–77) 0.900
IL-1β 7 (2–8) 11 (3–67) 0.391 1 (1–1) 1 (1–1) 0.351
IL-6 89 (66–204) 291 (34–804) 0.755 4 (2–24) 8 (3–17) 0.561
IL-8 13805 (10746–18785) 16906 (1990–24330) 0.640 293 (72–1131) 893 (112–1805) 0.384
IL-10 12 (6–31) 18 (2–53) 0.211 1 (1–1) 1 (1–1) 0.609
IP-10 698 (282–1613) 478 (16–3078) 0.406 1 (1–117) 33 (1–94) 0.387
IFN-γ ^^ 54 (7–385) 347 (124–615) 0.029 16 (3–38) 45 (10–105) 0.097
IFN-γ levels and Percentage of IFN-γ+ cells at 24 hours
NK cells 10 (6–12) 14 (7–18) 0.213 8 (2–13) 8 (1–16) 0.836
γδ T cells 5 (3–6) 8 (7–16) 0.013 7 (4–10) 9 (2–15) 0.967
Vδ2 cells 4 (3–6) 12 (9–24) 0.003 7 (3–10) 9 (2–16) 0.520
Vδ1 cells 2 (1–10) 8 (2–15) 0.096 10 (4–15) 6 (2–15) 0.534
Data are median (interquartile range). PNG: Papua New Guinea; N: Non-malaria infected women; AUS: Australia
�: Mann-Whitney Test; Primi: Primigravidae; Multi: Multigravidae; P values in Bold: Statistically significant
^^: Cytokine level at 24 hours.
https://doi.org/10.1371/journal.pone.0236375.t004
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Discussion
This study used an in vitro approach to explore how active malaria infection, lifetime malaria
exposure and gravidity influence early cellular immune responses, comparing pregnant
women from PNG and Australia. When IE were used as the stimulus, active malaria infection
did not substantially alter responses, but PBMCs from malaria-exposed PNG women secreted
more inflammatory cytokines, and more of their NK cells produced IFN-γ+ than the malaria-
naïve Australian cohort. Patterns of IFN-γ production and secretion with exposure to preg-
nancy-associated IE showed some gravidity-dependent differences in PNG women, indicating
a potential role for acquired immunity. Higher cytokine secretion in PNG women than Aus-
tralian women in response to PHA stimulation suggested broader immune activation in PNG.
Geography and gravidity may affect the responsiveness of maternal innate cells to malaria IE
and other stimuli.
Malaria infection, confirmed by both microscopy and qPCR, was not associated with gen-
eral differences in inflammatory cytokine responses. Although cells from non-infected women
produced higher levels of IFN-γ at 48 h than cells from infected women, this difference was
not apparent at 24 h. In addition, the proportions of IFN-γ producing NK and γδ T cells were
not different between these groups, and secretion of no other tested cytokines differed. These
data suggest that the functional activity and inflammatory responses of maternal PBMC are
not substantially altered by concurrent exposure to malaria parasites. Although we cannot
exclude the possibility of occult placental malaria, in agreement with our results, the propor-
tion of NK cells and IFN-γ production in peripheral blood were reported to be similar between
infected and non-infected pregnant women in Western Kenya [38].
On exposure to CS2 IE, PBMC derived from PNG pregnant women had higher proportions
of functional NK cells and produced stronger inflammatory responses than samples obtained
Table 5. Cytokine secretion and cellular responses to PHA and uRBC.
PHA uRBC
PNG_N AUS P value � PNG_N AUS P value �
n = 26 n = 30 n = 26 n = 30
Cytokine levels at 48 hours (pg/ml)
TNF-α 754 (19–1323) 1 (1–9) <0.001 1 (1–1) 1 (1–1) 0.942
IFN-γ 2 (1–4057) 38 (1–148) 0.953 7 (2–240) 1 (1–1) 0.006
IL-1β 36(2–97) 1 (1–1) <0.001 1 (1–1) 1 (1–1) 0.061
IL-6 1241 (34–5622) 5 (2–13) <0.001 8 (4–88) 1 (1–1) <0.001
IL-8 7338 (2932–14059) 732 (134–1474) <0.001 14 (1–83) 1 (1–3) 0.002
IL-10 69 (1–183) 1 (1–1) <0.001 1 (1–1) 1 (1–1) 0.061
IP-10 1 (1–987) 5 (1–93) 0.677 1 (1–1) 1 (1–1) 0.115
IFN-γ ^^ 1369 (390–3416) 35 (7–68) <0.001 0.1 (0.1–0.2) 0.1 (0.1–3) 0.874
Percentage of IFN-γ+ cells at 24 hours
NK cells 8 (6–19) 4 (1–14) 0.024 0.1 (0.1–1) 0.1 (0.1–1.0) 0.992
γδ T cells 3 (2–17) 5 (2–18) 0.593 0.1 (0.1–2) 0.1 (0.1–1.4) 0.440
Vδ2 T cells 3 (2–20) 2 (0.3–15) 0.243 0.1 (0.1–2) 0.1 (0.1–1.4) 0.954
Vδ1 T cells 7 (3–19) 9 (1–22) 0.954 0.1 (0.1–3) 0.1 (0.1–1.3) 0.960
Data are median (interquartile range). PHA: Phytohemagglutinin; uRBC: Uninfected erythrocytes; PNG: Papua New Guinea; N: Non-malaria infected women; AUS:
Australia
�: Mann-Whitney Test; P values in Bold: Statistically significant
^^: Cytokine level at 24 hours.
https://doi.org/10.1371/journal.pone.0236375.t005
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from Australian residents. The reasons for the marked differences in cytokine secretion
between the two groups are not known. It has been proposed that host genetic determinants
such as the NK-cell killer immunoglobulin-like receptor repertoire can influence early IFN-γ
responses to P. falciparum IE [16, 39], and differences in genetic background between the two
cohorts might explain the difference in cellular responses, but would require further investiga-
tion. A further possibility is trained immunity, induced either by exposure to malaria [40] or
to other stimuli [41], and resulting in transcriptional or epigenetic reprogramming of innate
immune cells to produce more active inflammatory responses. The lower levels of some cyto-
kines seen in both PNG and Australian women using P6A1 IE rather than CS2 IE may reflect
the ability of CD36-binding IE to be taken up by non-opsonic phagocytosis through CD36 on
monocyte-lineage cells, with potentially inhibitory effects on cytokine secretion [42].
One potential implication of the differences in cytokine secretion may be a greater ability to
control parasitemia in the PNG cohort, perhaps indicating a form of functional immunity,
indicated by the increased functional responsiveness of NK cells and the rapid release of
inflammatory mediators in this group [38]. In line with this proposition, decreased activity of
NK cells and consequently insufficient IFN-γ production has been associated with severe pla-
cental malaria episodes [43, 44]. On the other hand, this could imply the vulnerability of PNG
women to adverse pregnancy outcomes, as elevations in cytokines such as TNF-α in placental
malaria have been correlated with LBW [17, 18, 21].
Although the elevated cellular responses observed with the PNG samples could be related to
prior malaria exposure, a similar pattern was observed with a non-malaria stimulus, PHA,
(and, to some extent with incubation with uRBC) suggesting that heightened responsiveness
was not malaria-specific, but may instead indicate greater immune activation in PNG than
Australian women. Possible factors underlying this difference might include exposure of PNG
women to a diverse range of communicable diseases, such as helminth and bacterial infections
[45]. Unfortunately, participants were not tested for infection with these pathogens, which
might have an impact on the responsiveness of the innate cellular repertoire to stimuli such as
IE and PHA [46]. This proposed general immune activation might overshadow the specific
effects of prior malaria exposure.
The increased susceptibility of primigravid women to malaria is partly explained by the gra-
vidity dependent acquisition of protection from placental malaria which is associated with the
acquisition of antibodies against VAR2CSA which opsonises IE infected with pregnancy-spe-
cific parasites [47, 48] and prevents their placental sequestration. Studies examining how cellu-
lar responses to IE may differ with gravidity are relatively few in number. In our study,
secretion of inflammatory mediators at 48 h was not influenced by gravidity in either study
cohort, but among women from PNG, elicited levels of IFN-γ at 24 h were significantly higher
in multigravid compared to primigravid women. This is consistent with a previous study from
Kenya using placental mononuclear cells [19]. The higher secretion was associated with a
higher proportion of IFN-γ producing γδ T cells, specifically the Vδ2+ subset, in multigravid
women compared to primigravid women. Recent studies suggest that γδ T cells are essential
for non-specific targeting of P. falciparum [49] and can show a “memory/recall” phenotype
[50–52]. With increased exposure to CSA-binding IE over successive pregnancies, women are
presumed to develop increased pregnancy-malaria specific IFN-γ responses. We did not have
sufficient cells to examine effects of CD36-binding IE on intracellular staining for IFN-γ, and
so could not confirm whether the gravidity dependent differences observed in PNG women
are restricted to pregnancy-associated IE.
In adults, γδ T cells particularly Vδ2+ Vγ9 γδ T cells express high levels of CD45RO which
is thought to exhibit a memory phenotype [53]. A higher proportion of CD45RO memory-like
T cells was reported in PM-negative multigravid women compared to women in earlier
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pregnancies [38], suggesting that it may be part of a memory immune response that could
improve anti-parasite immunity. However, CD45RO expression was not evaluated in the pres-
ent study and would be interesting for future studies to investigate.
Strengths of the study include testing PBMC from pregnant women from PNG and Austra-
lia, matched for gravidity, side by side with identical stimuli. Although PBMCs constitute a sig-
nificant proportion of adaptive immune cells, the stimulation timepoints (24–48 h) potentially
exclude significant contributions of adaptive immune cells to cytokine levels. As other studies
have observed [54, 55], the early (24–48 h) response from PBMCs reflects mainly activation of
innate immune cells including monocytes, NK cells and γδ T cells, while acquired responses
only became significant after 72 h or more in culture. Among PNG women, those without
malaria infection were negative by both microscopy and highly sensitive qPCR. No women in
either cohort had recognised immune disturbances. Possible study weaknesses include differ-
ences in gestation, maternal age and hemoglobin levels at the time of sample collection, and
differences in anticoagulant used, although the choice of anticoagulant was shown not to affect
cytokine responses to IE. Pregnancy is generally divided into an early implantation-related
inflammatory state, a prolonged quiescent state which persists throughout most of pregnancy,
and the return to an inflammatory state only at onset of parturition [56]. Of note, none of the
Melbourne women were in active labour, and gestation is not known to significantly alter
innate immune responses. We did not have sufficient material to test cells for evidence of epi-
genetic modifications characteristic of trained immunity [41]. Our analysis did not correct for
multiple comparisons due to the exploratory nature of the study, and our sample size was rela-
tively small (with 26–30 women in most groups), limiting our power to detect differences
between groups, and to analyse any differences in responses according to infecting species.
Finally, we did not routinely test participants for human immunodeficiency virus infection,
but the prevalence of HIV infection in ANCs in the region was only 1% at the time of sample
collection (Unger, HW, Bolnga JW; unpublished data).
Conclusions
In summary, the present study demonstrates that geographic origin and to some degree gra-
vidity can influence maternal innate immune responses to malaria IE. Women from PNG
exhibit rapid and higher inflammatory cytokine responses to both malaria and non-malaria
stimuli (IEs and PHA) than an Australian cohort, suggesting a broader immune activation and
perhaps an indication of functional immunity for PNG inhabitants. Furthermore, the expan-
sion of functional Vδ2 γδ T cells in multigravidae compared to primigravidae in PNG sug-
gested a potential memory phenotype and a role in gravidity-dependent protection against
clinical malaria. Host genetics, immune activation or epigenetic changes characteristic of
trained immunity, may explain the substantially higher inflammatory cytokine production,
and the modest increase in numbers of IFN-γ producing NK cells in PNG women compared
to Autralian pregnant women.
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